Aveanna Healthcare (NASDAQ:AVAH) Price Target Raised to $9.50

Aveanna Healthcare (NASDAQ:AVAH) had its price objective increased by investment analysts at UBS Group from $9.00 to $9.50 in a research note issued to investors on Friday,Benzinga reports. The firm currently has a “neutral” rating on the stock. UBS Group’s price objective suggests a potential upside of 8.57% from the company’s previous close.

A number of other research analysts have also weighed in on the stock. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Aveanna Healthcare in a research note on Wednesday, October 8th. Raymond James Financial upgraded shares of Aveanna Healthcare from a “market perform” rating to an “outperform” rating and set a $9.00 price objective on the stock in a research note on Monday, August 11th. Truist Financial upped their price objective on shares of Aveanna Healthcare from $9.50 to $10.00 and gave the company a “hold” rating in a report on Friday. Barclays raised Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and lifted their price target for the stock from $5.50 to $9.50 in a report on Tuesday, August 19th. Finally, Royal Bank Of Canada raised their target price on shares of Aveanna Healthcare from $8.00 to $10.00 and gave the stock a “sector perform” rating in a report on Friday, October 24th. Three analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $10.07.

Aveanna Healthcare Stock Performance

Shares of NASDAQ AVAH traded up $0.12 during mid-day trading on Friday, hitting $8.75. 1,381,278 shares of the stock were exchanged, compared to its average volume of 794,060. The stock’s fifty day simple moving average is $8.84 and its two-hundred day simple moving average is $6.45. Aveanna Healthcare has a twelve month low of $3.67 and a twelve month high of $10.32. The company has a market cap of $1.83 billion, a P/E ratio of 109.38 and a beta of 2.04.

Aveanna Healthcare (NASDAQ:AVAH) last released its earnings results on Monday, May 22nd. The company reported $0.04 earnings per share for the quarter. Aveanna Healthcare had a negative return on equity of 54.56% and a net margin of 0.85%.The company had revenue of $450.53 million during the quarter. As a group, equities research analysts predict that Aveanna Healthcare will post -0.06 earnings per share for the current fiscal year.

Insider Buying and Selling at Aveanna Healthcare

In other Aveanna Healthcare news, major shareholder Robert M. Williams, Jr. sold 1,500,000 shares of the stock in a transaction that occurred on Friday, October 24th. The stock was sold at an average price of $9.00, for a total value of $13,500,000.00. Following the transaction, the insider owned 362,746 shares in the company, valued at approximately $3,264,714. This represents a 80.53% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, major shareholder J.H. Whitney Equity Partners V sold 1,251,909 shares of Aveanna Healthcare stock in a transaction dated Friday, October 24th. The shares were sold at an average price of $9.00, for a total transaction of $11,267,181.00. Following the transaction, the insider owned 19,292,787 shares of the company’s stock, valued at $173,635,083. This represents a 6.09% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 32,597,968 shares of company stock valued at $293,381,712. Corporate insiders own 7.80% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in AVAH. Summit Partners L P bought a new position in Aveanna Healthcare in the 2nd quarter worth about $50,477,000. Strs Ohio purchased a new stake in shares of Aveanna Healthcare in the 1st quarter valued at $218,000. Teacher Retirement System of Texas increased its holdings in shares of Aveanna Healthcare by 50.9% in the first quarter. Teacher Retirement System of Texas now owns 49,881 shares of the company’s stock worth $270,000 after buying an additional 16,835 shares during the period. Diversified Trust Co purchased a new position in Aveanna Healthcare in the 2nd quarter worth approximately $57,000. Finally, MetLife Investment Management LLC raised its holdings in Aveanna Healthcare by 16.2% during the 1st quarter. MetLife Investment Management LLC now owns 31,251 shares of the company’s stock valued at $169,000 after buying an additional 4,349 shares during the last quarter. Institutional investors own 87.96% of the company’s stock.

Aveanna Healthcare Company Profile

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.